Home » Market News » DirectorsTalk Highlights » Avacta will be at WRIB
Avacta Group Plc

Avacta will be at WRIB

Attending WRIB next week? The Avacta team are, and will be found on booth 61.

A Week of Bioanalysis, Biomarkers, and Immunogenecity at WRIB

Avacta Group Plc (LON:AVCT) principal focus is on its proprietary Affimer® technology which is a novel engineered alternative to antibodies that has wide application in Life Sciences for diagnostics, therapeutics and general research and development.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.